IRIS - Res&Arch Institutional Research Information System - Research & Archive

SALVADORI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.553
AS - Asia 1.275
EU - Europa 1.121
SA - Sud America 234
AF - Africa 48
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.240
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.507
SG - Singapore 558
IT - Italia 394
BR - Brasile 194
CN - Cina 159
HK - Hong Kong 157
IE - Irlanda 151
RU - Federazione Russa 105
KR - Corea 93
DE - Germania 84
VN - Vietnam 76
FR - Francia 69
GB - Regno Unito 47
NL - Olanda 44
IN - India 41
SE - Svezia 39
FI - Finlandia 37
AT - Austria 30
TR - Turchia 29
BD - Bangladesh 24
RO - Romania 24
CA - Canada 23
JP - Giappone 21
IQ - Iraq 20
PH - Filippine 18
PL - Polonia 17
ES - Italia 16
ZA - Sudafrica 16
BE - Belgio 13
UA - Ucraina 13
AR - Argentina 10
CH - Svizzera 10
CO - Colombia 10
PK - Pakistan 10
MX - Messico 8
SA - Arabia Saudita 8
AU - Australia 7
EC - Ecuador 7
IR - Iran 7
EG - Egitto 6
ID - Indonesia 6
MA - Marocco 6
TN - Tunisia 6
UZ - Uzbekistan 6
MD - Moldavia 5
TW - Taiwan 5
CL - Cile 4
CZ - Repubblica Ceca 4
IL - Israele 4
JO - Giordania 4
KH - Cambogia 4
LB - Libano 4
MY - Malesia 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
LT - Lituania 3
OM - Oman 3
PA - Panama 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
UY - Uruguay 2
AM - Armenia 1
CV - Capo Verde 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IS - Islanda 1
ML - Mali 1
MR - Mauritania 1
MW - Malawi 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 4.240
Salva come PNG Salva come JPEG
Città #
Singapore 448
Chandler 191
San Jose 184
Dublin 147
Hong Kong 147
Perugia 136
Ashburn 108
Santa Clara 64
Boardman 58
San Mateo 56
The Dalles 47
Moscow 42
Beijing 38
Lauterbourg 38
Los Angeles 37
Altamura 34
Ann Arbor 32
Redmond 31
Dearborn 28
Medford 28
Munich 28
New York 28
Princeton 27
Seoul 27
Vienna 26
Ho Chi Minh City 23
São Paulo 22
Wilmington 22
Andover 20
Bucharest 20
Bologna 18
Lawrence 18
Seongnam-si 18
Orem 14
Tokyo 14
Brussels 13
Piscataway 13
Falkenstein 12
Hanoi 12
Warsaw 12
Amsterdam 11
Falls Church 11
Milan 11
Denver 10
Johannesburg 10
London 10
Montreal 10
Nuremberg 10
Turku 10
Cebu City 9
Dallas 9
Istanbul 9
Parma 9
Baghdad 8
Boston 8
Council Bluffs 8
Frankfurt am Main 8
Groningen 8
Helsinki 8
Atlanta 7
Chennai 7
Da Nang 7
Mumbai 7
Phoenix 7
Redwood City 7
Rome 7
Seodaemun-gu 7
Toronto 7
Brasília 6
Brooklyn 6
Collazzone 6
Des Moines 6
Glasgow 6
Houston 6
Incheon 6
Norwalk 6
Saint Petersburg 6
Cairo 5
Columbus 5
Dhaka 5
Dong Ket 5
Hefei 5
San Francisco 5
Stockholm 5
Turin 5
Ankara 4
City of London 4
Florence 4
Jakarta 4
Jinju 4
Karaj 4
Konya 4
Lahore 4
Mainz 4
Olomouc 4
Paris 4
Pavia 4
Phnom Penh 4
Raisio 4
Rio de Janeiro 4
Totale 2.675
Salva come PNG Salva come JPEG
Nome #
Histological muscle characterization in hypertrophied Marchigiana cattle breed 174
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 171
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 149
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 147
RAGE in the pathophysiology of skeletal muscle. 146
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 140
Equisetum arvense standardized extract hinders age-related sarcopenia 139
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 139
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 137
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 136
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 136
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 134
Natural products to counteract muscle atrophy 131
Screening of 100 plant extracts for the development of a herbal product effective against muscle atrophy 128
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 126
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 126
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 124
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 114
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 110
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 109
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 107
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 107
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 107
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 105
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 103
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 101
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 101
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 100
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 99
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 97
The receptor RAGE: a potential molecular target in cancer cachexia 92
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 91
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 87
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 80
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 76
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 74
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 65
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 51
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 11
Totale 4.370
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 3 6
2021/2022290 3 40 9 17 6 8 8 75 10 32 43 39
2022/2023548 30 104 3 49 44 61 1 25 198 2 22 9
2023/2024286 15 23 5 23 8 21 80 4 4 14 22 67
2024/20251.143 43 83 134 70 112 55 113 118 146 68 143 58
2025/20261.674 102 88 73 216 229 158 309 115 175 151 58 0
Totale 4.370